Panca Mitra Multiperdana Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Panca Mitra Multiperdana Tbk. trades at Rp50 (market cap 129.42B), while Charlie Hospital Semarang Tbk. trades at Rp430 (market cap 1.11T, 25.61M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 8.6× Panca Mitra Multiperdana Tbk.'s market cap. Which is the better fit depends on your goals.
| PMMP | RSCH | |
|---|---|---|
Market Cap | 129.42B | 1.11T |
Volume | — | 25.61M |
Lot | — | 256.07K |
Turnover | — | 10.76B |
Average Price | — | 420.16 |
Value | — | 10.76B |
Indicative Equilibrium Price | — | 430 |
Indicative Equilibrium Volume | — | 1.46K |
Trailing returns across standard periods
Latest headlines on both assets
PT Panca Mitra Multiperdana Tbk (the Company) was established in Jakarta based on Notarial Deed No. 52 of Buntario Tigris Darmawa Ng, S.H., S.E., Candidate Notary, dated August 8, 1997. The Company commenced its commercial activity in 1997. The Company’s immediate parent company is PT Tiga Makin Jaya, which is ultimately owned by Soesilo Soebardjo.
Read more on PMMP →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →